vindesine has been researched along with Lymphoma in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (47.06) | 18.7374 |
| 1990's | 10 (29.41) | 18.2507 |
| 2000's | 5 (14.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (8.82) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, T; Li, Z; Qiu, X; Sun, K; Tao, H; Wu, Z; Zhong, M | 1 |
| Al-Quteimat, OM | 1 |
| Chen, CK; Hayashi, S; Ikari, K; Kusano, J; Ogai, A; Ozawa, Y; Yamamoto, R; Yoshida, R | 1 |
| Berthou, C; Colombat, P; Deconinck, E; Delwail, V; Foussard, C; Gaillard, F; Gressin, R; Harousseau, JL; Lucas, V; Milpied, N | 1 |
| Berneman, Z; Bosly, A; Bron, D; Dauwe, M; De Bock, R; Ferrant, A; Kaufman, L; Van Hoof, A; Verhoef, G | 1 |
| Amiel, JL; Ben Ayed, F; Droz, JP; Spielmann, M; Tursz, T | 1 |
| Berris, R; DiBella, NJ; Fink, K; Garfield, D; Sakamoto, A; Speer, J | 1 |
| Iwata, N; Maekawa, T; Oike, S; Omine, M; Tsuchiya, J; Umegae, S; Wakamatsu, E | 1 |
| Chello, PL; Hancock, C; Miller, DR; Miller, LP; Sirotnak, FM; Tan, CT | 1 |
| Ishigami, S; Kubota, Y; Kusakabe, H; Masaoka, T; Nakamura, H; Saigo, K; Shibata, H; Takubo, T; Ueda, T; Yoshitake, J | 1 |
| Carcassonne, Y; Gastaut, JA; Maraninchi, D; Tubiana, N | 1 |
| Ferrazzi, E; Fiorentino, MV; Galligioni, E; Pappagallo, GL; Salvagno, L; Segati, R; Vinante, O; Zagonel, V | 1 |
| Amadori, S; Antonietta, M; Giona, F; Mandelli, F; Meloni, G; Paolucci, G; Pastore, S; Spiriti, A | 1 |
| Chester, AB; Dorr, RT; Jones, SE; Miller, TP | 1 |
| Dancey, J; Steward, WP | 1 |
| Alberto, P; Bauer, J; Iten, PA; Laurencet, FM; Mermillod, B; Zulian, GB | 1 |
| Sun, Y; Wang, J; Zhang, H | 1 |
| Camacho, FJ; O'Connell, MJ; Oken, MM; Phillips, V; Wiernik, PH | 1 |
| Biron, P; Bordessoule, D; Bosly, A; Brière, J; Coiffier, B; Dupriez, B; Herbrecht, R; Lederlin, P; Mounier, N; Nouvel, C; Sebban, C; Tilly, H | 1 |
| Baumelou, E; Brousse, C; Morel, P | 1 |
| Coiffier, B; Fillet, G; Gabarre, J; Gisselbrecht, C; Guilmin, F; Hermine, O; Lederlin, P; Lepage, E; Molina, T; Quesnel, B; Reyes, F; Tilly, H | 1 |
| Bastion, Y; Blanc, M; Coiffier, B; Dumontet, C; Felman, P; Ffrench, M; Peaud, PY | 1 |
| Andrien, F; Auzanneau, G; Bosly, A; Coiffier, B; Devaux, Y; Gisselbrecht, C; Herbrecht, R; Jaubert, J; Legros, M; Tilly, H | 1 |
| Berger, F; Brousse, N; Coiffier, B; Gisselbrecht, C; Herbrecht, R; Salles, G; Tilly, H | 1 |
| Arai, N; Hara, A; Shirai, T; Umeda, M | 1 |
| Di Noto, R; Fabbiano, F; Gentile, S; Guarnaccia, C; Indovina, A; Majolino, I; Patti, C; Santoro, A; Scimè, R; Vasta, S | 1 |
| Furukawa, Y; Hiyoshi, M; Im, T; Inoue, T; Kishida, T; Okuda, K; Park, K; Sasaki, A; Tatsumi, N; Yamane, T | 1 |
| Straus, DJ | 1 |
| Bosly, A; Brousse, N; Coiffier, B; Gisselbrecht, C; Herbrecht, R; Tilly, H | 1 |
| Hamada, H; Ishida, Y; Minato, K; Ohtsu, T; Shimoyama, M; Sugimoto, Y; Tobinai, K; Tsuruo, T | 1 |
| Akabane, T; Fujimoto, T; Hattori, M; Ise, T; Ito, M; Maekawa, T; Masaoka, T; Miyazaki, T; Sakurai, M; Taguchi, N | 1 |
| Jurd, J; Vincent, PC; Young, GA | 1 |
| Hancock, BW | 1 |
2 review(s) available for vindesine and Lymphoma
| Article | Year |
|---|---|
The role of vindesine in oncology--recommendations after 10 years' experience.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials as Topic; Humans; Leukemia; Lung Neoplasms; Lymphoma; Melanoma; Vindesine | 1995 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |
15 trial(s) available for vindesine and Lymphoma
| Article | Year |
|---|---|
Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Female; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Prednisone; Remission Induction; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Vincristine; Vindesine | 2004 |
[Salvage chemotherapy in resistant malignant lymphomas (author's transl)].
Topics: Adolescent; Adult; Bleomycin; Cisplatin; Clinical Trials as Topic; Dacarbazine; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Vinblastine; Vindesine | 1982 |
[Administration of vindesine sulfate for the treatment of malignant hematological tumors].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Male; Middle Aged; Vinblastine; Vincristine; Vindesine | 1982 |
Vindesine in the treatment of refractory hematologic malignancies: a phase II study.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow; Child; Drug Evaluation; Drug Resistance; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Vinblastine; Vindesine | 1982 |
Feasibility, toxicity, and activity of LNH84-derived chemotherapy in the management of aggressive lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Feasibility Studies; Female; Humans; Lymphoma; Male; Middle Aged; Prednisolone; Survival Rate; Vindesine | 1997 |
[Results of phase II clinical trial of vindesine in the treatment of malignant tumors].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; China; Female; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Prospective Studies; Vindesine | 1996 |
Methylguazone, vindesine and cisplatin for the treatment of patients with relapsed or refractory malignant lymphoma: an Eastern Cooperative Oncology Group Study (PA482).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lymphoma; Male; Middle Aged; Mitoguazone; Survival Analysis; Treatment Outcome; Vindesine | 1998 |
Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Humans; Immunophenotyping; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Prospective Studies; Remission Induction; Survival Analysis; Vincristine; Vindesine | 2000 |
Primary lymphoma of bone: a prospective study of 28 cases.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Surveys and Questionnaires; Survival Rate; Treatment Outcome; Vindesine | 2000 |
Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vindesine | 2002 |
Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lymphoma; Middle Aged; Prednisolone; Prognosis; Prospective Studies; Survival Rate; Vindesine | 1991 |
Treatment of malignant lymphomas with very-high-dose CVB followed by transplantation of autologous blood stem cells collected after mobilizing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Lymphoma; Middle Aged; Pancytopenia; Pulmonary Fibrosis; Radiotherapy; Remission Induction; Transplantation, Autologous; Vindesine | 1991 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |
LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Belgium; Bleomycin; Child; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; France; Humans; Lymphoma; Middle Aged; Multicenter Studies as Topic; Prednisolone; Prognosis; Random Allocation; Remission Induction; Vindesine | 1989 |
[Phase II and III studies of vindesine in children with leukemia and lymphoma].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Leukemia; Lymphoma; Male; Vincristine; Vindesine | 1986 |
18 other study(ies) available for vindesine and Lymphoma
| Article | Year |
|---|---|
Risk factors for high-dose methotrexate associated toxicities in patients with primary central nervous system lymphoma.
Topics: Acute Kidney Injury; Antimetabolites, Antineoplastic; Central Nervous System; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Humans; Lymphoma; Methotrexate; Risk Factors; Vindesine | 2022 |
Vincristine Shortage: What Other Options We Have?
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamide; Doxorubicin; Drug Substitution; Humans; Leukemia; Liposomes; Lymphoma; Prednisone; Vinblastine; Vincristine; Vindesine | 2020 |
[A Case of Adult T-Cell Leukemia/Lymphoma with Severe Hand-Foot Syndrome during Administration of Modified LSG15 Regimen].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hand-Foot Syndrome; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma; Middle Aged; Nitrosourea Compounds; Prednisolone; Vincristine; Vindesine | 2020 |
Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Patient Selection; Prednisone; Retrospective Studies; Survival Analysis; Time Factors; Vindesine | 2008 |
Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Humans; Lymphoma; Melanoma; Middle Aged; Vinblastine; Vindesine | 1984 |
[Phase II study of vindesine in hematological malignancies].
Topics: Adult; Child; Drug Evaluation; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Vinblastine; Vindesine | 1983 |
[A presumed transient hemolytic reaction following vinca alkaloids administration in patients with hematological malignancies].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hemolysis; Humans; Hyperbilirubinemia; Leukemia, Lymphoid; Lymphoma; Male; Middle Aged; Vinblastine; Vincristine; Vindesine | 1984 |
Sequential combination of methotrexate and vindesine in previously treated children with acute leukemia. A phase I-II study.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Drug Evaluation; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Methotrexate; Vinblastine; Vindesine | 1984 |
[Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Female; Hodgkin Disease; Humans; Infusions, Parenteral; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Vinblastine; Vindesine | 1981 |
Phase II evaluation of vindesine in mycosis fungoides, extraosseous plasmacytoma and other hematologic malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Digestive System; Drug Evaluation; Female; Humans; Leukemia, Lymphoid; Leukopenia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Mycosis Fungoides; Nervous System; Plasmacytoma; Vinblastine; Vindesine | 1982 |
Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.
Topics: Antineoplastic Agents; Bone Marrow Diseases; Breast Neoplasms; Drug Evaluation; Humans; Lymphoma; Neoplasms; Vinblastine; Vinca Alkaloids; Vindesine | 1980 |
Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma; Male; Middle Aged; Survival Rate; Treatment Outcome; Vindesine | 1992 |
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma; Male; Middle Aged; Multivariate Analysis; Prednisolone; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Survival Analysis; Vindesine | 1992 |
[Salvage chemotherapy with IMV-triple P for relapsed or refractory malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Evaluation; Female; Heart; Humans; Ifosfamide; Leukopenia; Lymphoma; Male; Middle Aged; Mitoxantrone; Peplomycin; Prednisolone; Procarbazine; Remission Induction; Survival Rate; Thrombocytopenia; Vindesine | 1991 |
Therapy with mitoxantrone, ifosfamide, vindesine, and prednisolone for malignant lymphoma with adjustable doses and timing of courses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Humans; Ifosfamide; Leukocyte Count; Lymphoma; Mitoxantrone; Vindesine | 1991 |
Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16.
Topics: Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dactinomycin; Daunorubicin; Doxorubicin; Drug Resistance; Etoposide; Gene Expression; Humans; Leukemia; Lymphoma; Membrane Glycoproteins; Mitoxantrone; RNA, Messenger; Tumor Cells, Cultured; Vinblastine; Vincristine; Vindesine | 1989 |
Vindesine in the treatment of refractory haematological malignant diseases.
Topics: Adolescent; Adult; Aged; Female; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Lymphoma; Male; Middle Aged; Vinblastine; Vindesine | 1985 |
Vindesine, etoposide (VP-16), and prednisolone (VEP) in relapsed patients with grade II non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Prednisolone; Vinblastine; Vindesine | 1985 |